Skip to Content
Schedule

Latin America Healthcare Compliance Certificate

Schedule

Latin America Healthcare Compliance Certificate Program

PROGRAM SCHEDULED for March 24-27, 2025 | In-Person/Hybrid | Mexico City, Mexico

[email protected] | 973-642-8382

All times are in Mexico City time (Central Standard Time)

 

Day 1

9:00 - 9:30am

Welcome, Overview Introductions & Ice Breaker

Rosa Alves

Rosa M. Alves

Assistant Dean for Global Compliance & Programming, Seton Hall Law School (New Jersey, United States)

Learn more about Rosa M. Alves

Timothy Glynn

Timothy Glynn

Andrea J. Catania Endowed Professor of Law, Seton Hall Law School (New Jersey, United States)

Learn more about Timothy Glynn

9:35 - 10:30

Aligning the “Why” and “How” of Compliance

  • A look at why business ethics is an important part of compliance and a company’s culture.
Timothy Glynn

Timothy Glynn

Andrea J. Catania Endowed Professor of Law, Seton Hall Law School (New Jersey, United States)

Learn more about Timothy Glynn

10:30 - 10:45

Break

10:45 - 12:15

Advertising & Promotion of Drugs & Medical Devices 

  • A discussion of the key requirements and regulations for advertising and promoting prescription drugs and medical devices, special risk areas for pre-launch activities, and social media.

 

Ignacio Gillmore

Ignacio Gillmore

Partner & Co-Head, Life Sciences and Biotechnology & Public Law Groups, Carey Law Firm (Santiago)

Learn more about Ignacio Gillmore

Nicole Recchi Aun

Nicole Recchi Aun

Senior Associate, Life Sciences, Pinheiro Neto Advogados (São Paulo)

Learn more about Nicole Recchi Aun  

Adrián del Paso

Adrián del Paso

Partner & Chair, Environmental, Life Sciences, Healthcare
& Regulatory Practices, Assembla (Mexico City) 

Learn more about Adrián del Paso 

Martín Javier Mosteirin

Martín Javier Mosteirin

Partner of the Life Sciences and Healthcare Departments, Marval (Buenos Aires)

Learn more about Martín Javier Mosteirin

Camila Leone

Camila Leone

Member, Life Sciences & Healthcare Department, Marval (Buenos Aires)

Learn more about Camila Leone

Luciano Hoffmann

Moderator: Luciano Hoffmann

Country Legal Head, Novartis Brazil (São Paulo)

Learn more about Luciano Hoffmann 

12:15 - 1:15

Lunch

1:15 - 2:30

Drug & Device Development & Approval Process

  • A comprehensive overview of the laws/regulations and key requirements involved in the new drug and device approval process, including classifying and testing new products, the application process, and the various pathways to marketing a product.

 

Patrícia Fukuma

Patrícia Fukuma

Partner, Fukuma Advogados & Consultores (São Paulo)

Learn more about Patrícia Fukuma

Luis Joaquín Serrano Sánchez

Luis Joaquín Serrano Sánchez

Country Manager, IRIS Global LLC (Mexico City)

Learn more about Luis Joaquín Serrano Sánchez

2:35 - 3:35

Transparency in Latin America 

  • An overview of the disclosure reporting requirements for transfers of value to health care professionals; what are the risks and what have we learned from other regions.

 

Lorena Schiariti

Lorena Schiariti 

Partner & Member, Regulatory Law Team & Compliance,
Anticorruption, and Investigations Team, Marval (Buenos Aires)

Learn more about Lorena Schiariti

Gabriela Morette

Gabriela Morette

Privacy Director, LatAm, Global Privacy, Johnson & Johnson (São Paulo)

Learn more about Gabriela Morette

3:35 - 3:50

Break

3:50 - 4:45

Culture, Ethics and Compliance

Maria Leonor de Freitas Rios

Maria Leonor de Freitas Rios

Founding Partner, Freitas Rios Advogados Associados (São Paulo)

Learn more about Maria Leonor de Freitas Rios

 

Day 2

9:30 - 10:30

Global Anti-Corruption Enforcement 

  • A session focusing on the Foreign Corruption Practices Act, the UK Bribery Act, and global anti-corruption enforcement.
Jonathan Stevens

Jonathan Stevens

Partner, Litigation Department, Paul Hastings, LLP

View Bio

10:30 - 10:45

Break

10:45 - 12:00

Anti-Corruption Risks & Enforcement in LATAM Markets 

  • Key risk areas for the life sciences industry, including with respect to third parties, global anti-corruption laws, industry trends, and lessons learned from other high-risk markets.

 

Heloisa Barroso Bloisi

Heloisa Barroso Bloisi

Partner, Trench Rossi Watanabe (São Paulo)

Learn more about Heloisa Barroso Bloisi 

Felipe Ferenzini

Felipe Ferenzini

Partner, Trench Rossi Watanabe (São Paulo)

Learn more about Felipe Ferenzini

12:00 - 1:00

Lunch Break

1:00 - 2:00

Antitrust Regulations in the Life Sciences Industry

Camilla Paoletti

Camilla Paoletti

Partner, Competition Practice Area, BMA Advogados (São Paulo)

Learn more about Camilla Paoletti 

2:05 - 3:15

Conducting an Internal Investigation 

  • An examination of what conduct triggers the need for an internal investigation, who should be involved, and how to handle the results.

 

Gildas Durand

Gildas Durand

Principal/Partner, Fraud Investigation & Dispute Services (FIDS), Ernst & Young (EY)(Miami, United States)

Learn more about Gildas Durand

Bryan Parr

Bryan Parr

Of Counsel, Gibson Dunn (Washington, DC, United States)

Learn more about Bryan Parr

3:15 - 3:30

Break

3:30 - 4:45

Compliance Officers’ Panel Discussion

Caterina Fazenda

Caterina Fazenda

Latam Executive Director for Legal & Compliance, Ultragenyx (São Paulo)

Learn more about Caterina Fazenda

Fernando Fagundes Iazzetta

Fernando Fagundes Iazzetta

Legal & Compliance Officer China & International -  Legal & Corporate Affairs, Chiesi Farmaceutica Ltda (São Paulo)

Learn more about Fernando Fagundes Iazzetta

Lilian Lustre

Lilian Lustre

Head of Ethics & Business Integrity for Latam & Member of E&BI Global Leadership Team, Sanofi (São Paulo)

Learn more about Lilian Lustre 

Adriana Fussuma

Adriana Mayumi Fussuma

Legal & Compliance Head LATAM, Medison Pharma (São Paulo)

Learn more about Adriana Mayumi Fussuma

Timothy Glynn

Timothy Glynn

Andrea J. Catania Endowed Professor of Law, Seton Hall Law School (New Jersey, United States)

Learn more about Timothy Glynn

4:45 - 6:00

Networking Reception

Timo Cucina, Vila Olímpia

Avenida Presidente Juscelino Kubitschek, 1909, São Paulo

 

 

Day 3

9:30 - 10:45

Talking To Your Government: Dealing with Enforcers & Prosecutors 

  • A discussion of the interaction and policies that exist between the private and public sectors and how to navigate government relations.
Paulo Rosito

Paulo Rosito

Partner of Life Sciences & Healthcare, Souto Correa Advogados (São Paulo)

Learn more about Paulo Rosito 

Anderson Ribeiro

Anderson Ribeiro Oliver

Life Sciences - Partner, Souto Correa Advogados (São Paulo)

Learn more about Anderson Ribeiro Oliver

Michel Sancovski

Michel Sancovski

Partner, Global Investigations & White Collar Defense, Mayer Brown LLP (São Paulo)

Learn more about Michel Sancovski 

10:45 - 11:00

Break

11:00 - 12:10

Strengthening Compliance Programs Through Data Analytics 

  • A look at what data analytics is and how it can be used to help detect, predict, and prevent future compliance risks.

 

Roberta Martinho

Roberta Martinho

Senior Manager, Forensic & Integrity Services, Ernst & Young (EY) (São Paulo) 

Learn more about Roberta Martinho

Adriana Fussuma

Adriana Mayumi Fussuma

Legal & Compliance Head LATAM, Medison Pharma (São Paulo)

Learn more about Adriana Mayumi Fussuma

12:10 - 1:10

Lunch Break

1:10 - 2:20

Monitoring Programs

  • Monitoring, auditing, and how to improve upon these programs within your companies. 

 

Andre Souza

Andre Souza

Senior Manager, Global Assessment & Consulting Services (GACS)
LatAm, Johnson & Johnson (São Paulo)

Learn more about Andre Souza

2:25 - 3:35

Data Protection Risks in the Health Care Industry—An Accountability Approach 

  • Overview of the key data protection risks facing multinationals; the complex regulatory landscape for privacy and data protection in LATAM & globally.

 

Benny Spiewak

Benny Spiewak

Founding Partner, SPLAW Advogados (São Paulo)

Learn more about Benny Spiewak

3:35 - 3:50

Break

3:50 - 5:00

Assessing Third Party Risk 

  • Best practices on how to conduct tiered due diligence and implement internal controls to mitigate the risks associated with third parties.

 

Patricia Miguel

Patricia Miguel

Partner, Forensic & Integrity Services, Ernst & Young (EY) (São Paulo)

Learn more about Patricia Miguel 

Flavia Paulino

Flavia Paulino

Compliance Director LATAM, Novo Nordisk (São Paulo)

 

Day 4

9:00 - 10:10

Industry Interactions with Patient Organizations 

  • Discussion of the types of industry interactions with patients and patient organizations and how to identify and manage the ethical issues and potential conflicts of interest that may arise.
Júlio Garcia Morais

Júlio Garcia Morais

Partner, Lopes Muniz Advogados (São Paulo)

Learn more about Júlio Garcia Morais 

10:10 - 10:25

Break

10:25 - 11:25

Building a Compliance Team & Creating a Culture of Compliance 

  • An examination of ways to recruit, develop, and promote a team of compliance professionals; interactive exercise describing methods that companies can use with employees to help build an ethical business culture.

 

Fernando Fagundes Iazzetta

Fernando Fagundes Iazzetta

Legal & Compliance Officer China & International -  Legal & Corporate Affairs, Chiesi Farmaceutica Ltda (São Paulo)

Learn more about Fernando Fagundes Iazzetta

11:30 - 12:30

Interactive Team Case Study - Group Exercise

12:30 - 1:30

Lunch Break

1:30 - 2:15

Interactive Team Case Study - Group Exercise

2:20 - 3:45

Interactive Team Case Study

Caterina Fazenda

Caterina Fazenda

Latam Executive Director for Legal & Compliance, Ultragenyx (São Paulo)

Learn more about Caterina Fazenda

3:45

Closing remarks & Awarding of Program Certificates

Rosa Alves

Rosa M. Alves

Assistant Dean for Global Compliance & Programming, Seton Hall Law School (New Jersey, United States)

Learn more about Rosa M. Alves

Learn More